<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">CM</journal-id><journal-title-group><journal-title>Chinese Medicine</journal-title></journal-title-group><issn pub-type="epub">2151-1918</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/cm.2015.61002</article-id><article-id pub-id-type="publisher-id">CM-54148</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  miRNAs Expression and Role of Dicer on Podocyte Injury in PAN Nephrosis Rats
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>hunqing</surname><given-names>Li</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Wei</surname><given-names>Sun</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Haochang</surname><given-names>Du</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Dong</surname><given-names>Zhou</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jihong</surname><given-names>Chen</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Lu</surname><given-names>Zhang</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jiade</surname><given-names>Shao</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>1</addr-line></aff><aff id="aff4"><addr-line>Nephrology Department of Jiangsu Province Hospital of Traditional Chinese Medicine, Nanjing, China</addr-line></aff><aff id="aff3"><addr-line>Discipline of Chinese and Western Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, China</addr-line></aff><aff id="aff2"><addr-line>Nephrology Department of Wuxi No. 3 Hospital, Wuxi, China</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>jssunwei@163.com(WS)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>06</day><month>02</month><year>2015</year></pub-date><volume>06</volume><issue>01</issue><fpage>13</fpage><lpage>19</lpage><history><date date-type="received"><day>1</day>	<month>January</month>	<year>2015</year></date><date date-type="rev-recd"><day>accepted</day>	<month>12</month>	<year>February</year>	</date><date date-type="accepted"><day>16</day>	<month>February</month>	<year>2015</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Objective: microRNAs (miRNAs) are regulatory RNAs that act as important players in diverse biologic and pathologic processes. Under circumstance as podocye-injury triggering proteinuria, which miRNAs are up-regulated or down-regulated? This experiment aims at detecting miRNAs changes in PAN nephrosis rats based on miRNA arrays and exploring the therapeutic targets of Leizhi capsule. Methods: Fifty male wistar rats were randomly divided into five groups, including control group, model group, leizhi capsule group, 
  <em>Tripterygium glucosides</em> group, and valsartan group. PAN nephrosis models were made by jugular vein injection of PAN (100 mg/kg body weight, dissolve in physiological saline), while control group rats were made by jugular vein injection of physiological saline with equal volume. Other groups rats had been given medicines by irrigating stomach once a day for ten days. Blood and urine samples were collected, and renal tissues were processed after rats being euthanasised. The 24 h urinary protein excretion and blood biochemistry parameters were measured by routine methods. The glomerular morphology and podocyte ultrastructure were observed with light microscopy and transmission electron microscopy respectively. miRNA expression profile was detected by Exiqon miRNA Array. Real time RT-PCR analysis for mature miRNAs was used to validate differentially expressed miRNAs. Results: 1) In day 3 - 5, model rats had decreased urine volume, ascites, malnutrition and wight loss. From day 7 to day 10, the nephrotic syndromes were worst in model rats, but which had no skin edema. Some rats died in serious ascites, the mortality is 3/10. 2) miRNA array detection shows 106 miRNAs up regulated and 62 miRNAs down regulated in PAN nephrosis rats. Fold change (model vs. control group) varies from 1.8 to 7.0. For leizhi capsule group and model sample, there are 90 miRNAs differentially expressed, with 65 miRNAs up and 25 miRNAs down. The most important finding in our research is the discovery of the specific miRNAs related to PAN nephrosis (rno-miR23a, rno-miR-24, rno-miR-30c and rno-miR-300-3p), which have been validated by Real time RT-PCR analysis. 3) Compared with control sample, immune fluorescence intensity of dicer, expression profile of nephrin, podocin and synaptopodin mRNA and protein decrease in PAN nephrosis rats. After treated with Leizhi Capsule, immune fluorescence intensity of the above molecules improved. Conclusion: 1) Characteristic miRNAs of PAN nephrosis were screening. Up-regulated miRNAs (rno-miR-23a, rno-miR-300-3p) may trigger podocyte injury and proteinuria, while down-regulated miRNAs (rno-miR-24, rno-miR-30c) may be protective factors by anti-apoptosis. 2) Dicer and these miRNAs (rno-miR-24, rno-miR-30c, rno-miR-23a) may be are probably key molecules therapeutic targets of Leizhi capsule.
 
</p></abstract><kwd-group><kwd>microRNAs</kwd><kwd> Podocyte Injury</kwd><kwd> Puromycin Aminonucleoside Nephrosis Model</kwd><kwd> Proteinuria</kwd><kwd> Leizhi Capsule</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>microRNAs (miRNA) are a group of non-coding small RNA (approximately 22-nt) that are present in lower through higher organism and function to regulate gene expression by translation repression or transcript degradation of target genes. Dicer is a key enzyme in miRNA biosynthetic, by which pri-miRNAs are processed into approximately 22-nt mature microRNA [<xref ref-type="bibr" rid="scirp.54148-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.54148-ref2">2</xref>] . In addition, Dicer is involved in the immediate downstream effecter steps of this pathway, whereby it serves as an essential component of miRNA-containing catalytic enzyme complexes, such as the RNA-induced silencing complex. Thus, as a physical platform and a functional bridge, Dicer couples miRNA biogenesis to miRNA-mediated gene silence [<xref ref-type="bibr" rid="scirp.54148-ref3">3</xref>] .</p><p>Proteinuria is a dangerous factor of chronic kidney disease (CKD). Podocyte injury is not only the key link of proteinuria, but also closely contacts with CKD progress. Some microRNAs may induce slit diaphragm (SD) molecules expression via triggering nephrin phosphorylation to reduce proteinuria [<xref ref-type="bibr" rid="scirp.54148-ref4">4</xref>] -[<xref ref-type="bibr" rid="scirp.54148-ref6">6</xref>] . As a key enzyme of miRNA biosynthesis, dicer probabaly have a role on proteinuria of CKD. Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis [<xref ref-type="bibr" rid="scirp.54148-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.54148-ref7">7</xref>] , also alter cytoskeletal dynamics and causes glomerular disease [<xref ref-type="bibr" rid="scirp.54148-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.54148-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.54148-ref8">8</xref>] , leading to rapid glomerular and tubular injury [<xref ref-type="bibr" rid="scirp.54148-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.54148-ref9">9</xref>] . It is suggested that dicer and these miRNAs are probably key regulated targets. How dicer enzyme have effects on podocyte in PAN (puromycin aminonucleoside, PAN) nephrosis pathlogy? So the aim of our experiment is to explore how dicer has effects on podocyte apotosis and cytoskeleton.</p></sec><sec id="s2"><title>2. Methods</title><p>Fifty male Wistar rats were divided into five groups, including: 1) control group, 2) PAN model group, 3) leizhi group, 4) Tripterygium glucosides (GTW) group, and 5) valsartan group.</p><p>PAN model rats were made by jugularly intravenous injecting with PAN (100 mg/kg) [<xref ref-type="bibr" rid="scirp.54148-ref10">10</xref>] , while control group rats were made by intravenous injecting with physiological saline. After injection, all rats were feeding with clear water and food for ten days in metabolic cage.</p><p>By irrigation stomach once a day for ten days, all rats had been given medicines as follows:</p><p>1) Physiological saline (2 ml) for control group and model group;</p><p>2) Tripterygium glucosides (2 mg) dissolved in Erzhi (containing Ligustrum lucidum and Drought Ephraim grass) solusion (1 ml) for Leizhi group;</p><p>3) Tripterygium glucosides 1 mg/kg/d for Tripterygium glucosides group;</p><p>4) Triptolid 2 mg/200g/d for triptolid group ;</p><p>5) Valsartan valsartan 1.5 mg/200g/d for valsartan group.</p><p>Urine was collected on alternate day, and blood sample were gathered before and after experiment. After all rats being euthanasised, kidneys and livers were removed for Electron microscopy, Immunofluorescence stain and RT-PCR and western bloting.</p><p>miRNA Array analysis has been accomplished by Shanghai KangChen Biological engineering company. miRNA expression profile was detected by Exiqon miRNA Array, including: prepare the RNA Sample and RNA Sample QC, miRNA labeling, miRNA array hybridization, miRNA array scanning and analysis. Real time RT-PCR analysis for mature miRNAs was used to validate 4 differentially expressed miRNAs between control and model group in microRNA microarray assays.</p></sec><sec id="s3"><title>3. Results</title><p>PAN nephrosis rats were made successfully by jugular vein injection of PAN (100 mg/kg body weight). In day 5, model rats were in low spirits, with decreased urine volume, ascites, malnutrition and weight loss. From day 7 to day 10, proteinueia for 24 h were worst in PAN model rats, but without skin edema, see <xref ref-type="table" rid="table1">Table 1</xref>. Some rats died of serious ascites, the mortality is 30% (3/10).</p><p>Morphologic changes in light microscope include epithelial cells degeneration renal tubular and transparent cast, but there are no obvious changes in glomerulus and renal interstitial. Podocyte processes effacement was obvious in model groups sample in electronic microscope. See in <xref ref-type="fig" rid="fig1">Figure 1</xref>.</p><p>miRNA array detection shows 106 miRNA up regulated and 62 miRNA down regulated in PAN nephrosis rats. Fold change (model vs. control group) vary from 1.8 to 7.0. For leizhi capsule high-dose group and model sample, there are 90 miRNA differentially expressed, with 65 up and 25 down. see <xref ref-type="fig" rid="fig2">Figure 2</xref> and <xref ref-type="fig" rid="fig3">Figure 3</xref>.</p><p>The most important finding in our study is the discovery of the specific miRNA related to PAN nephrosis (rno-miR 23a , rno-miR-24, rno-miR -30c and rno-miR-300-3p, which have been validated by Real time RT-PCR analysis. See <xref ref-type="table" rid="table2">Table 2</xref>.</p><p>Compared with control sample, Immune Fluorescence intensity of nephrin, podocin and synaptopodin reduced in model sample. See in <xref ref-type="fig" rid="fig3">Figure 3</xref>. In addition, apoptosised podocytes increase in PAN sample.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Proteinuria for 24 h among each group</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Group</th><th align="center" valign="middle" >Dose mg∙kg<sup>−1</sup></th><th align="center" valign="middle" >Pre-trial</th><th align="center" valign="middle" >3 d</th><th align="center" valign="middle" >9 d</th></tr></thead><tr><td align="center" valign="middle" >NS</td><td align="center" valign="middle" >−</td><td align="center" valign="middle" >4.63 &#177; 1.82</td><td align="center" valign="middle" >4.43 &#177; 1.05</td><td align="center" valign="middle" >5.33 &#177; 1.69</td></tr><tr><td align="center" valign="middle" >PNS</td><td align="center" valign="middle" >−</td><td align="center" valign="middle" >5.29 &#177; 2.68</td><td align="center" valign="middle" >73.45 &#177; 68.76<sup>1)</sup></td><td align="center" valign="middle" >90.04 &#177; 65.38<sup>1)</sup></td></tr><tr><td align="center" valign="middle" >Leizhi</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >4.81 &#177; 3.77</td><td align="center" valign="middle" >38.24 &#177; 13.41<sup>2)</sup></td><td align="center" valign="middle" >28.23 &#177; 15.26<sup>2)</sup></td></tr><tr><td align="center" valign="middle" >GTW</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >6.82 &#177; 4.09</td><td align="center" valign="middle" >54.68 &#177; 25.32<sup>2) 3)</sup></td><td align="center" valign="middle" >33.23 &#177; 14.14<sup>2)</sup></td></tr><tr><td align="center" valign="middle" >Valsartan</td><td align="center" valign="middle" >7.5</td><td align="center" valign="middle" >5.47 &#177; 1.68</td><td align="center" valign="middle" >44.46 &#177; 17.66<sup>2)</sup></td><td align="center" valign="middle" >23.09 &#177; 5.41<sup>2)</sup></td></tr></tbody></table></table-wrap><p>Compared with NS group, <sup>1)</sup>representing p &lt; 0.05, compared with PNS group, <sup>2)</sup>representing p &lt; 0.05, compared with Leizhi group, <sup>3)</sup>representing p &lt; 0.05.</p><table-wrap-group id="2"><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> miRNAs expression by miRNA Array and realtime RT PCR. (a) miRNA expression (model versus NS). (b) miRNA expression (leizhi versus PAN)</title></caption><table-wrap id="2_1"><caption><title> (b)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >miRNA</th><th align="center" valign="middle" >miRNA Array</th><th align="center" valign="middle" >Realtime RT PCR</th></tr></thead><tr><td align="center" valign="middle" >rno-mir-24</td><td align="center" valign="middle" >0.32</td><td align="center" valign="middle" >0.312</td></tr><tr><td align="center" valign="middle" >rno-mir-30c</td><td align="center" valign="middle" >0.30</td><td align="center" valign="middle" >0.555</td></tr><tr><td align="center" valign="middle" >rno-mir-23a</td><td align="center" valign="middle" >3.23</td><td align="center" valign="middle" >2.472</td></tr><tr><td align="center" valign="middle" >rno-mir-300-3p</td><td align="center" valign="middle" >2.93</td><td align="center" valign="middle" >2.514</td></tr></tbody></table></table-wrap><table-wrap id="2_2"><caption><title></title></caption><table><tbody><thead><tr><th align="center" valign="middle" >miRNA</th><th align="center" valign="middle" >miRNA Array</th><th align="center" valign="middle" >Realtime RT PCR</th></tr></thead><tr><td align="center" valign="middle" >rno-mir-24</td><td align="center" valign="middle" >3.49</td><td align="center" valign="middle" >0.312</td></tr><tr><td align="center" valign="middle" >rno-mir-30c</td><td align="center" valign="middle" >2.32</td><td align="center" valign="middle" >0.555</td></tr><tr><td align="center" valign="middle" >rno-mir-23a</td><td align="center" valign="middle" >0.50</td><td align="center" valign="middle" >2.472</td></tr><tr><td align="center" valign="middle" >rno-mir-300-3p</td><td align="center" valign="middle" >0.53</td><td align="center" valign="middle" >2.514</td></tr></tbody></table></table-wrap></table-wrap-group><fig-group id="fig1"><label><xref ref-type="fig" rid="fig1">Figure 1</xref></label><caption><title> Change of foot process of glomerular podocyte in PAN rats. (a) NS, (b) PAN, (c) Leizhi, (d) GTW (8000&#215;).</title></caption><fig id ="fig1_1"><label> (b)</label><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/2-8801271x6.png"/></fig><fig id ="fig1_2"><label> (c)</label><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/2-8801271x7.png"/></fig><fig id ="fig1_3"><label> (d)</label><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/2-8801271x8.png"/></fig><fig id ="fig1_4"><label></label><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/2-8801271x9.png"/></fig></fig-group><fig-group id="fig2"><label><xref ref-type="fig" rid="fig2">Figure 2</xref></label><caption><title> Differentially expressed miRNAs screening by miRNA Arrays. (a) Up-expressed miRNAs; (b) Down-expressed miRNAs.</title></caption><fig id ="fig2_1"><label> (b)</label><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/2-8801271x10.png"/></fig><fig id ="fig2_2"><label></label><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/2-8801271x11.png"/></fig></fig-group><fig id="fig3"  position="float"><label><xref ref-type="fig" rid="fig3">Figure 3</xref></label><caption><title> Immunoflunce of dicer, nephrin, podocin, and synodopotoptin in glomerular. (a) NS, (b) PAN, (c) Leizhi, (d) GTW</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/2-8801271x12.png"/></fig></sec><sec id="s4"><title>4. Discussion</title><p>PAN nephrosis rats can be made successfully by jugular vein injection of PAN. PAN can selectively injury podocytes but not mesangium or endothelial cells in glomerular, inducing proteinuria, foot process effacement, and glomerular basement membrane abnormalities. So PAN nephrosis has been a classic podocyte-injury model.</p><p>Dicer is key to miRNA mature, which can mentain podocyte function and structure of SD in kidney. Our results show that dicer correlates well with proteinuria, but correlating negatively with nephrin and podocin. The most important finding in our study is the specific miRNA related to PAN nephrosis (rno-miR 23a , rno-miR-24, rno-miR -30c and rno-miR-300-3p), which have been validated by Real time RT-PCR analysis. Up-regulated miRNAs (rno-miR-23a, rno-miR-300-3p) may trigger podocyte injury and proteinuria, while down-regulated miRNAs (rno-miR-24, rno-miR-30c) may be protective factors by anti-apoptosis. These miRNA may function corporately, because they located in the same chromesome [<xref ref-type="bibr" rid="scirp.54148-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.54148-ref12">12</xref>] . To explore dicer role in glomerular function, Harvey [<xref ref-type="bibr" rid="scirp.54148-ref8">8</xref>] et al. used a conditional Dicer allele to disrupt miRNA biogenesis in mouse podocytes. Mutant mice developed proteinuria and progressed rapidly to end-stage kidney disease. The pathology included foot process effacement, vacuolization, and hypertrophy with crescent formation. Their findings demonstrate a critical role for miRNA in glomerular function and suggest that podocyte may participate in the pathogenesis of kidney diseases. Shi [<xref ref-type="bibr" rid="scirp.54148-ref7">7</xref>] et al. inactivated dicer selectively in mouse podocytes. Mutant mice developed proteinuria 4 to 5 weeks after birth and died several weeks later, presumably from kidney failure. Multiple abnormalities including foot process effacement, irregular and split areas of the glomerular basement membrane, podocyte apoptosis and depletion, and glomerulosclerosis were observed. Four members of the mir-30 miRNA family were identified, known to be expressed and/or functional in podocytes. These results suggest functional roles for the mir-30 miRNA family in podocyte homeostasis and podocytopathies. Ho [<xref ref-type="bibr" rid="scirp.54148-ref9">9</xref>] et al. generated mice lacking functional miRNAs in the developing podocyte through podocyte-specific knockout of Dicer, Podocyte- specific loss of miRNAs resulted in significant proteinuria, rapid progression of marked glomerular and tubular injury, and death. Expression of the slit diaphragm proteins nephrin and podocin was decreased, and expression of the transcription factor WT1 remained unchanged. To identify miRNA-mRNA interactions that contribute to this phenotype, they profiled the glomerular expression of miRNAs; three miRNAs expressed in glomeruli were identified: mmu-miR-23b, mmu-miR-24, and mmu-miR-26a. These results suggest that miRNA function is dispensable for the initial development of glomeruli but is critical to maintain the glomerular filtration barrier. Connect to the database of miRNA Base [<xref ref-type="bibr" rid="scirp.54148-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.54148-ref14">14</xref>] , target genes of miR-24, miR-23a and miR-30c correlate with phosphatase phosphatkinase and Protease C, suggesting these miRNA may participate in nephrin phosphorylation in podocyte homeostasis and podocyte injury.</p><p>Dicer can be down-regulated in PAN induced rats treated with Tripterygium preparation. Expression profile of nephrin, podocin and synaptopodin mRNA and protein decrease in samples treated with Tripterygium wilfordii Hook by triggering dicer-miRNA, which play the podocyte protection role by inhibiting podocyte apotosis. So these miRNAs (rno-miR-24, rno-miR-30c, rno-miR -23a ) and dicer may be target moculars of leizhi capsule on treating proteinuria in PAN nephrosis. They may be are probably key molecules therapeutic targets.</p><p>From our work, we can conclude that characteristic miRNAs of PAN nephrosis were screening. Up-regulated miRNAs (rno-miR-23a, rno-miR-300-3p) may trigger podocyte injury and proteinuria, while down-regulated miRNAs (rno-miR-24, rno-miR -30c ) may be protective factors by anti-apoptosis. Dicer and these miRNAs (rno- miR-24, rno-miR-30c, rno-miR -23a ) may be are probably key molecules therapeutic targets of Leizhi capsule. But the fine mechanisms remain to be clarified by more researches.</p></sec><sec id="s5"><title>Acknowledgements</title><p>miRNA Array analysis has been accomplished by Shanghai Kang Chen Biological engineering company.</p></sec><sec id="s6"><title>Financial Support</title><p>The experiment is funded by Jiangsu province natural science fund (BK2009462) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).</p></sec><sec id="s7"><title>Conflict of Interest Statement</title><p>The authors declare no conflicts of interest.</p></sec><sec id="s8"><title>NOTES</title></sec></body><back><ref-list><title>References</title><ref id="scirp.54148-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Lee, R.C., Feinbaum, R.L. and Ambros, V. (1993) The C. elegans Heterochronic Gene lin-4 Encodes Small RNAs with Antisense Complementarity to lin-14. Cell, 75, 843-854. http://dx.doi.org/10.1016/0092-8674(93)90529-Y</mixed-citation></ref><ref id="scirp.54148-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Reinhart, B.J., Slack, F.J., Basson, M., et al. (2000) The 21-Nucleotide let-7 RNA Regulates Developmental Timing in Caenorhabditis elegans. Nature, 403, 901-906. http://dx.doi.org/10.1038/35002607</mixed-citation></ref><ref id="scirp.54148-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Muljo, S.A., Kanellopoulou, C. and Aravind, L. (2010) MicroRNA Targeting in Mammalian Genomes: Genes and Mechanisms. Wiley Interdisciplinary Reviews: Systems Biology and Medicine, 2, 148-161. http://dx.doi.org/10.1002/wsbm.53</mixed-citation></ref><ref id="scirp.54148-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Ohashi, T., Uchida, K., Asamiya, Y., et al. (2010) Phosphorylation Status of Nephrin in Human Membranous Nephropathy. Clinical and Experimental Nephrology, 14, 51-55. http://dx.doi.org/10.1007/s10157-009-0241-z</mixed-citation></ref><ref id="scirp.54148-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Welsh, G.I. and Saleem, M.A. (2010) Nephrin-Signature Molecule of the Glomerular Podocyte? Journal of Pathology, 220, 328-337.</mixed-citation></ref><ref id="scirp.54148-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Qin, X.S., Tsukaguchi, H., Shono, A., et al. (2009) Phosphorylation of Nephrin Triggers Its Internalization by Raft-Mediated Endocytosis. Journal of the American Society of Nephrology, 20, 2534-2545. http://dx.doi.org/10.1681/ASN.2009010011</mixed-citation></ref><ref id="scirp.54148-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Shi, S., Yu, L., Chiu, C., et al. (2008) Podocyte-Selective Deletion of Dicer Induces Proteinuria and Glomerulosclerosis. Journal of the American Society of Nephrology, 19, 2159-2169. http://dx.doi.org/10.1681/ASN.2008030312</mixed-citation></ref><ref id="scirp.54148-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Harvey, S.J., Jarad, G., Cunningham, J., et al. (2008) Podocyte-Specific Deletion of Dicer Alters Cytoskeletal Dynamics and Causes Glomerular Disease. Journal of the American Society of Nephrology, 19, 2150-2158. http://dx.doi.org/10.1681/ASN.2008020233</mixed-citation></ref><ref id="scirp.54148-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Ho, J., Ng, K.H., Rosen, S., et al. (2008) Podocyte-Specific Loss of Functional microRNAs Leads to Rapid Glomerular and Tubular Injury. Journal of the American Society of Nephrology, 19, 2069-2075. http://dx.doi.org/10.1681/ASN.2008020162</mixed-citation></ref><ref id="scirp.54148-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Liu, L.H., Zhu, C.F. and Ou, L.Z. (2005) Optimization and Evaluation of Puromycin Amioenucleoside Nephropathy Model in Rats. Fudan University Journal of Medical Sciences, 32, 488-492.</mixed-citation></ref><ref id="scirp.54148-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Chhabra, R., Dubey, R. and Saini, N. (2010) Cooperative and Individualistic Functions of the microRNAs in the miR-23a~27a~24-2 Cluster and Its Implication in Human Diseases. Molecular Cancer, 9, 232. http://dx.doi.org/10.1186/1476-4598-9-232</mixed-citation></ref><ref id="scirp.54148-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Chhabra, R., Adlakha, Y.K., Hariharan, M., et al. (2009) Upregulation of miR-23a-27a-24-2 Cluster Induces Caspase-Dependent and -Independent Apoptosis in Human Embryonic Kidney Cells. PLoS One, 4, e5848. http://dx.doi.org/10.1371/journal.pone.0005848</mixed-citation></ref><ref id="scirp.54148-ref13"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Griffiths-Jones</surname><given-names> S. </given-names></name>,<etal>et al</etal>. (<year>2010</year>)<article-title>miRBase: microRNA Sequences and Annotation</article-title><source> Current Protocols in Bioinformatics</source><volume> 12</volume>,<fpage> 12</fpage>-<lpage>19</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.54148-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Griffiths-Jones, S., Grocock, R.J., van Dongen, S., et al. (2006) miRBase: microRNA Sequences, Targets and Gene Nomenclature. Nucleic Acids Research, 34, D140-D144. http://dx.doi.org/10.1093/nar/gkj112</mixed-citation></ref></ref-list></back></article>